 |
市場調查報告書
商品編碼
1529919
鼻腔給藥市場：按容器形式、按應用、按最終用戶、按地區Intranasal Drug Delivery Devices Market, By Dosage Form, By Application (Chronic Obstructive Pulmonary Disease, Rhinitis, Cystic Fibrosis, Nasal Congestion, Asthma, Others), By End User, By Geography |
||||||
預計2024年全球鼻腔給藥裝置市場規模為17億美元，預計2031年將達32.7億美元，2024年至2031年複合年成長率為9.8%。
| 報告範圍 | 報告詳情 | ||
|---|---|---|---|
| 基準年 | 2023年 | 2024年市場規模 | 17億美元 |
| 實際資料 | 2019-2023 | 預測期 | 2024-2031 |
| 2024-2031 年預測期複合年成長率 | 9.80% | 2031 年金額預測 | 32.7億美元 |
全球鼻腔給藥市場的成長是由鼻腔給藥的相關優勢所推動的，例如避免首過肝臟代謝、藥物快速吸收進入體循環以及從鼻子直接進入大腦等。鼻腔給藥允許透過非侵入性途徑進行局部和全身給藥。專注於開發先進鼻噴霧和霧化器技術的公司增加產品推出和進行大量投資可能會推動市場成長。
市場動態：
鼻腔給藥裝置的全球市場成長是由對替代給藥途徑的偏好、需要長期藥物治療的慢性病盛行率上升以及鼻腔給藥裝置的技術進步所推動的。鼻腔給藥的非侵入性和快速起效鼓勵各種藥物開發商開拓此途徑。然而，鼻吸收藥物分子大小的限制以及鼻刺激和鼻塞風險等因素可能會阻礙市場成長。專注於增加適用藥物分子的種類和製定更安全的鼻腔給藥技術的持續研究和開發可以為市場成長提供利潤豐厚的機會。
本研究的主要特點
該報告對全球鼻腔給藥裝置市場進行了詳細分析，並提供了以2023年為基準年的預測期（2024-2031年）的市場規模（十億美元）和年複合成長率（CAGR%）。發表。
它還揭示了各個細分市場的潛在商機，並解釋了該市場中有吸引力的投資提案的矩陣。
它還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景、主要企業採取的競爭策略等的主要考察。
它根據公司亮點、產品系列、主要亮點、財務表現和策略等參數，介紹了全球鼻給藥設備市場的主要企業。
主要企業包括 OptiNose、默克、葛蘭素史克、阿斯特捷利康、賽諾菲等。
該報告的見解使負責人和公司經營團隊能夠就未來的產品發布、升級、市場擴張和行銷策略做出明智的決策。
全球鼻給藥裝置市場報告迎合了該行業的各種相關人員，如投資者、供應商、產品製造商、經銷商、新進業者和財務分析師。
目錄
第1章 研究目的與前提
- 研究目的
- 先決條件
- 簡稱
第2章 市場展望
- 報告說明
- 市場定義和範圍
- 執行摘要
- 一致的機會地圖 (COM)
第3章市場動態、法規及趨勢分析
- 市場動態
- 促進因素
- 抑制因素
- 機會
- 影響分析
- 市場趨勢
- 監管場景
- 收購和合作場景
- 資金籌措和投資
- PEST分析
- 波特的分析
第4章全球鼻腔給藥裝置市場 - 冠狀病毒 (COVID-19) 大流行的影響
- 整體影響
- 政府舉措
- COVID-19 對市場的影響
第5章 2019-2031 年全球經皮給藥裝置市場（按劑型）（十億美元）
- 介紹
- 鼻噴劑
- 滴鼻劑
- 鼻凝膠
- 滴鼻劑
第6章 全球鼻腔給藥裝置市場，以容器形式，2019-2031 年（十億美元）
- 介紹
- 加壓容器
- 非加壓容器
第7章 2019-2031 年全球鼻腔給藥裝置市場（按應用分類）（十億美元）
- 介紹
- 慢性阻塞性肺病（COPD）
- 鼻炎
- 囊腫纖維化
- 鼻塞
- 氣喘
- 其他
第 8 章 全球鼻腔給藥裝置市場，依最終用戶分類，2019-2031 年（十億美元）
- 介紹
- 門診手術中心
- 診所
- 醫院
- 其他
第9章2019-2031年全球鼻腔給藥裝置市場（按地區）（十億美元）
- 介紹
- 拉丁美洲
- 歐洲
- 亞太地區
- 中東
第10章競爭格局
- 公司簡介
- GlaxoSmithKline PLC
- AstraZeneca PLC
- Pfizer, Inc.
- OptiNose, Inc.
- 3M Company
- Becton, Dickinson and Company
- Promius Pharma, LLC
- Cadila Pharmaceuticals Ltd.
- BF Ascher &Company, Inc.
- PendoPharm, Inc.
- Douglas Pharmaceuticals Ltd.
- ENT Technologies Pty. Ltd.
- NAVEH Pharma Ltd.
- Novartis AG
- Neurelis, Inc.
- Aptargroup, Inc.
第11章分析師建議
- 上升和下降
- 綜合機會圖
第12章參考文獻與調查方法
- 參考
- 調查方法
Global intranasal drug delivery devices market is estimated to be valued at USD 1.70 Bn in 2024 and is expected to reach USD 3.27 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 9.8% from 2024 to 2031.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2023 | Market Size in 2024: | US$ 1.70 Bn |
| Historical Data for: | 2019 To 2023 | Forecast Period: | 2024 to 2031 |
| Forecast Period 2024 to 2031 CAGR: | 9.80% | 2031 Value Projection: | US$ 3.27 Bn |
Global intranasal drug delivery devices market growth is driven by factor like advantages associated with intranasal drug delivery such as avoidance of first-pass hepatic metabolism, rapid drug absorption into systemic circulation, and direct nose-to-brain delivery. Intranasal drug delivery provides a non-invasive route for administering both local and systemic drugs. Rising product launches and substantial investments from players focused on developing advanced nasal spray and nebulizer technologies can drive the market growth.
Market Dynamics:
Global intranasal drug delivery devices market growth is driven by growing preference for alternate routes of drug delivery, rising incidence of chronic illnesses requiring long-term drug therapies, and technological advancements in nasal drug delivery devices. Non-invasive nature and rapid onset of action offered by intranasal delivery encourages various drug developers to explore this route. However, factors such as limitations on drug molecule size for intranasal absorption and risks of nasal irritation and congestion can hamper the market growth. Ongoing R&D focused on expanding the repertoire of applicable drug molecules and formulating safer nasal drug delivery technologies can offer market growth lucrative opportunities.
Key Features of the Study:
This report provides in-depth analysis of the global intranasal drug delivery devices market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global intranasal drug delivery devices market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include OptiNose, Merck, GlaxoSmithKline, AstraZeneca, and Sanofi
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
Global intranasal drug delivery devices market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Detailed Segmentation-
- By Dosage Form
- Nasal Spray
- Nasal Drop
- Nasal Gel
- Nasal Powder
- By Container Type
- Pressurized Containers
- Non-pressurized Containers
- By Application
- Chronic Obstructive Pulmonary Disease (COPD)
- Rhinitis
- Cystic Fibrosis
- Nasal Congestion
- Asthma
- Others
- By End User
- Ambulatory Surgical Centres
- Clinics
- Hospitals
- Others
- By Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East
- Africa
- Company Profiles:
- GlaxoSmithKline PLC
- AstraZeneca PLC
- Pfizer, Inc.
- OptiNose, Inc.
- 3M Company
- Becton, Dickinson and Company
- Promius Pharma, LLC
- Cadila Pharmaceuticals Ltd.
- F. Ascher & Company, Inc.
- PendoPharm, Inc.
- Douglas Pharmaceuticals Ltd.
- ENT Technologies Pty. Ltd.
- NAVEH Pharma Ltd.
- Novartis AG
- Neurelis, Inc.
- Aptargroup, Inc.
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snapshot, By Dosage Form
- Market Snapshot, By Container Type
- Market Snapshot, By Application
- Market Snapshot, By End User
- Market Snapshot, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Opportunities
- Impact Analysis
- Market Trends
- Key Developments
- Regulatory Scenario
- Acquisitions and Partnerships Scenario
- Funding and Investments
- PEST Analysis
- Porter's Analysis
4. Global Intranasal Drug Delivery Devices Market - Impact of Coronavirus (COVID-19) Pandemic
- Overall Impact
- Government Initiatives
- COVID-19 Impact on the Market
5. Global Intranasal Drug Delivery Devices Market, By Dosage Form, 2019 - 2031, (USD Bn)
- Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
- Nasal Spray
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Nasal Drop
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Nasal Gel
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Nasal Powder
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
6. Global Intranasal Drug Delivery Devices Market, By Container Type, 2019 - 2031, (USD Bn)
- Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
- Pressurized Containers
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Non-pressurized Containers
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
7. Global Intranasal Drug Delivery Devices Market, By Application, 2019 - 2031, (USD Bn)
- Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
- Chronic Obstructive Pulmonary Disease (COPD)
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Rhinitis
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Cystic Fibrosis
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Nasal Congestion
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Asthma
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
8. Global Intranasal Drug Delivery Devices Market, By End User, 2019 - 2031, (USD Bn)
- Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
- Ambulatory Surgical Centers
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Clinics
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Hospitals
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
9. Global Intranasal Drug Delivery Devices Market, By Region, 2019 - 2031, (USD Bn)
- Introduction
- Market Share Analysis, By Region, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, For Region, 2020-2031
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Container Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Container Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Container Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Container Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Container Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Container Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2019 - 2031, (USD Bn)
- North Africa
- Central Africa
- South Africa
10. Competitive Landscape
- Company Profiles
- GlaxoSmithKline PLC
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- AstraZeneca PLC
- Pfizer, Inc.
- OptiNose, Inc.
- 3M Company
- Becton, Dickinson and Company
- Promius Pharma, LLC
- Cadila Pharmaceuticals Ltd.
- B.F. Ascher & Company, Inc.
- PendoPharm, Inc.
- Douglas Pharmaceuticals Ltd.
- ENT Technologies Pty. Ltd.
- NAVEH Pharma Ltd.
- Novartis AG
- Neurelis, Inc.
- Aptargroup, Inc.
- GlaxoSmithKline PLC
11. Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
12. References and Research Methodology
- References
- Research Methodology
- About Us and Sales Contact
